- AU, EU Deepen Health Partnership with €100 Million Investment in Africa’s Health Systems
- Iran Conflict Could Push Condom Prices Up 30 Percent, Warns Manufacturer
- Merck Once-Daily ARV Pill Could Reach Market Soon
- Global South Pressures EU to Finalise Equity Clause in Pandemic Agreement
- Health Minister Dr Mombeshora Appeals for End to Nurses’ Strike
HIV vaccines tested in PrEPVacc fail to reduce infections
The results of the PrEPVacc HIV vaccine trial conducted in Eastern and Southern Africa, which ran between 2020 and 2024, show conclusively that neither of the two experimental vaccine regimens tested reduced HIV infections among the study population. Vaccinations in the PrEPVacc trial were stopped in November 2023 (and publicly announced in December 2023) when
Read More
Dr Agnes Mahomva Appointed to WHO Afro’s Emergencies Technical Advisory Group
By Michael Gwarisa Zimbabwe’s Public Health Advisor to the President and Cabinet, Dr Agnes Mahomva together with 16 other African health leaders have been appointed to the African Region, the World Health Organization Regional Office for Africa Emergency Preparedness & Response Technical Advisory Group (EPR-TAG). The independent body serves as the principal advisory group to
Read MoreAll Set For Southern African Regional Students and Youth Conference
By Michael Gwarisa An estimated 250 delegates are set to grace the fifth edition of the Southern African Regional Students and Youth Conference (SARSYC) that will run from July 17-19, 2024 in Gaborone, Botswana. The conference will attract speakers from diverse young people groups as well as experienced public health experts, development partners and government
Read More
AMR Threatens SDGs Attainment In Africa
By Michael Gwarisa The World Health Organisation (WHO) data shows that Africa remains heavily burdened with antimicrobial resistance (AMR) compared to all WHO Regions. Africa also has the highest mortality from AMR despite the region having the lowest prevalence of resistance. In 2015, after realising the need for urgent action to combat the growing scourge
Read MoreHope on the Horizon As New TB Vaccine Trials Kick Off
Hundred years later after the first Tuberculosis Vaccine was developed, a new TB vaccine is on the horizon. By Mandy Collins Imagine a world where TB doesn’t steal millions of lives each year. That dream might be inching closer, thanks to a groundbreaking vaccine trial kicking off in South Africa. Towards the end of March
Read MoreCommunity-based TB treatment highly effective in Togo
By Staff Reporter New research finds that a community-based approach to delivering TB treatment is highly effective at achieving successful TB treatment outcomes in Togo. The Union led the study in partnership with Togo’s National TB Programme (NTP) and the World Health Organization’s Special Programme for Research and Training in Tropical Diseases. The researchers found
Read MoreAfrican Region Triumphs Over Wild Polio Type 1
Brazzaville/Lilongwe/Maputo – Following thorough assessments in Malawi and Mozambique, an independent Polio Outbreak Response Assessment Team (OBRA) today recommended the closure of the wild poliovirus type 1 (WPV1) outbreak in Malawi and Mozambique, marking a significant milestone in the fight against polio in the African region. The last WPV1 case in the African Region, linked
Read MoreNamibia reaches key milestone in eliminating mother-to-child transmission of HIV and hepatitis B
Windhoek – Namibia has become the first country in Africa – and the first high-burden country in the world – to reach a significant milestone on the path towards eliminating vertical mother-to-child transmission of both HIV and viral hepatitis B. Eastern and Southern Africa is home to more than half the world’s HIV burden and
Read MoreGEAR Project Boosts Access To Quality Education For Vulnerable School Girls In Three African Countries
By Michael Gwarisa The GEAR (Girls Education Advocacy in the Region) project, an initiative aimed at enhancing access to quality education, has made significant progress in advancing quality education for girls in Zimbabwe, Zambia and Malawi. Valued at US$828 000, the project is a collaborative effort among four organizations from Malawi, Zambia, and Zimbabwe, termed
Read MoreIAS 2025 to take place in Kigali, Rwanda
2 May 2024 (Geneva, Switzerland) – IAS – the International AIDS Society – announced today that IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, from 14 to 17 July 2025. Pre-meetings will be held on 13 July. The conference will spotlight challenges and opportunities in some of the world’s most HIV-affected regions
Read More